 “There is always a better way”: Managing uncertainty in decision making about new cancer drugs in CanadaS. Michelle Driedger, Elizabeth Cooper, Gary Annable and Melissa Brouwers International Journal of Health Planning and Management, 2018, vol. 33, issue 2, e485-e499 Abstract: Policy decisions about the approval and funding of new cancer drugs must often be made in an environment of complex uncertainty about clinical and cost‐effectiveness data. The focus of this article is on the results from qualitative interviews with senior officials (n = 16) who make decisions about or influence cancer drug policy in various organizations in the Canadian cancer control system. Most participants identified the use of a limited number of informal approaches to address uncertainty, such as grounding decisions in evidence and advice from expert groups. People tended to focus on evidence informed decisions including price negotiations, the ability to implement policy changes, and stakeholder values. Lessons from the Canadian context related to continuing efforts to build a public culture of understanding into how policy decisions like cancer drug funding are made may result in greater acceptance and increased confidence in health policy decision‐making processes across multiple sectors internationally. Date: 2018 Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:bla:ijhplm:v:33:y:2018:i:2:p:e485-e499 Ordering information: This journal article can be ordered from Access Statistics for this article International Journal of Health Planning and Management is currently edited by Calum Paton More articles in International Journal of Health Planning and Management from Wiley Blackwell |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.